key: cord-0757554-wn7cirpb
authors: Li, Qi; Ran, Qingsen; Sun, Lidong; Yin, Jie; Luo, Ting; Liu, Li; Zhao, Zheng; Yang, Qing; Li, Yujie; Chen, Ying; Weng, Xiaogang; Wang, Yajie; Cai, Weiyan; Zhu, Xiaoxin
title: Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells
date: 2020-09-23
journal: Front Pharmacol
DOI: 10.3389/fphar.2020.522729
sha: 3a71ae959eeac91025624c52e4d94a7ce198953a
doc_id: 757554
cord_uid: wn7cirpb

Besides pathogen evading, Acute Lung Injury (ALI), featuring the systematic inflammation and severe epithelial damages, is widely believed to be the central non-infectious factor controlling the progression of infectious diseases. ALI is partly caused by host immune responses. Under the inspiration of unsuccessful treatment in COVID-19, recent insights into pathogen–host interactions are leading to identification and development of a wide range of host-directed therapies with different mechanisms of action. The interaction unit consisting of macrophages and the alveolar epithelial cells has recently revealed as the therapeutic basis targeting ALI. Lian Hua Qing Wen capsule is the most effective and commonly-used clinical formula in treating respiratory infection for thousands of years in China. However, little is known about its relevance with ALI, especially its protective role against ALI-induced alveolar tissue damages. Aiming to evaluate its contribution in antibiotics-integrating therapies, this study pharmacologically verified whether LHQW could alleviate lipopolysaccharide (LPS)-induced ALI and explore its potential mechanisms in maintaining the physiology of macrophage-epithelial unit. In ALI mouse model, the pathological parameters, including the anal temperature, inflammation condition, lung edema, histopathological structures, have all been systematically analyzed. Results consistently supported the effectiveness of the combined strategy for LHQW and low-dose antibiotics. Furthermore, we established the macrophages-alveolar epithelial cells co-culture model and firstly proved that LHQW inhibited LPS-induced ER stress and TRAIL secretion in macrophages, thereby efficiently protected epithelial cells against TRAIL-induced apoptosis. Mechanistically, results showed that LHQW significantly deactivated NF-κB and reversed the SOCS3 expression in inflammatory macrophages. Furthermore, we proved that the therapeutic effects of LHQW were highly dependent on JNK-AP1 regulation. In conclusion, our data proved that LHQW is an epithelial protector in ALI, implying its promising potential in antibiotic alternative therapy.

Acute lung injury (ALI), characterized by increased alveolar epithelial and lung epithelial permeability, followed by alveolar flooding and systematic inflammation, was considered as a common pathological mechanism and happened in most infectious diseases (Quartin et al., 2009) . ALI is often manifested as one of the most important mechanisms, which involves various tissues damage and eventually leads to multiple organ dysfunction (Oflazoglu et al., 2018) . Notably, among all the pathological processes within the ALI network, recent studies have found that aberrant macrophage activation followed by disturbed phenotypic switch are all closely linked with pathological changes in the development of ALI. They promote the lung inflammation and tissue damage, as well as the damage of pulmonary vascular permeability, resulting in pulmonary edema, are all closely linked with pathological changes in the development of ALI (Gordon, 2005; Imai et al., 2008) . Therefore, it is of great importance to confirm the relationship between ALI and tissue damage induced by macrophages, so as to provide new revelation in the treatment strategies of the respiratory infectious diseases system.

Disappointedly, in contrast to the essential roles of macrophages in ALI, drugs targeting macrophages regulation and tissue protection under inflammatory conditions are rarely mentioned at present. The treatment of pulmonary infectious diseases still focused on pathogen inhibition, frequently resulting in the upgrading of drug resistance and failure of treatment. This therapeutic dilemma has greatly inspired current researchers. Instead of simply pathogen eliminating, accumulating evidences have highlighted strategies focusing on immune-relevant mechanisms as represented by macrophage regulation and immunological balance remodeling of ALI. Particularly, coronavirus disease 2019, is rampant spreading all over the world. Due to the poorly understanding about this novel virus and the lacking of specific anti-virus drugs it has become the biggest threat for clinicians in the world (Li and De Clercq, 2020) . The lacking drugs of direct inhibition to the pathogen and non-pathogen treatment strategies have mostly contributed to an overwhelming threat of COVID-19. Hopefully, like a beam lightening the darkness, the traditional Chinese medicine (TCM), specialized in immune correcting and tissue protection under inflammatory conditions, plays decisive role in the pandemic controlling, which put another evidence for the importance and effectiveness of non-pathology-killing strategies against infectious respiratory diseases.

In ALI conditions, the pathogenesis of tissue damage, which can be seen as the indicator of pathological progress, is related to inflammatory reaction, cell apoptosis, necrosis and death. Particularly, tumor necrosis factor related apoptosis-inducing ligand (TRAIL) displays core role in regulating these processes and then contribute to pathological damage. Pathologically, the activation of proapoptotic and pro-necroptotic pathways, which can result in a structural disruption of the airway, is a major hallmark of pathological process controlled by TRAIL. In addition, TRAIL can also induce the disruption of the alveolar epithelial barrier by cell death, which significantly contributes to worsened unspecific tissue injury and disease severity in ALI (Tabas, 2010; Alessandri et al., 2013; Condamine et al., 2014; Huang et al., 2015) . Recent reports further suggested that TRAIL expression is mediated by ERS, which is linked to CHOP, a popular marker for assessment of ERS. A number of investigators have reported that suppression of ER stress markedly reduced the LPS-induced lung injury. Mechanically, ERS-induced TRAIL expression is mediated by the JNK/AP-1 signaling pathway, nevertheless the production of TRAIL induced by ERS was negatively controlled by SOCS3 through inhibiting phosphorylation of c-Jun via the JNK pathway.

Lian Hua Qing Wen capsules (LHQW) is the most effective and commonly-used clinical formula in treating respiratory infection for thousands of years in China. It has approved by China Food and Drug Administration (CFDA). LHQW is composed of 11 herbs including Forsythia suspensa (Thunb.) Vahl (Lianqiao); Lonicera japonica Thunb. (Jinyinhua); Honey-fried Ephedra sinica Stapf (Mahuang); Prunus armeniaca L. (Kuxingren); Isatis tinctoria L. (Banlangen); Dryopteris crassirhizoma Nakai (Mianmaguanzhong); Houttuynia cordata Thunb. (Yuxingcao); Pogostemon cablin Benth. (Guanghuoxiang); Rheum palmatum L. (Dahuang), Rhodiola crenulata (Hook.f. & Thomson) H.Ohba (Hongjingtian); and Glycyrrhiza glabra L. (Gancao); along with menthol (Bohenao) and a traditional Chinese mineral medicine, Gypsum Fibrosum (Shigao). Chemically, a total of 61 compounds were unambiguously or tentatively identified and divided into flavonoids, phenylpropanoids, anthraquinones, triterpenoids, iridoids, and other types by ultrahigh-performance liquid chromatography coupled with diode array detection and quadrupole time-of-flight mass spectrometry analysis (Jia et al., 2015) . Pharmacologically, the activities of individual components have been partially revealed (Table 1) . Pharmacological studies of LHQW have shown that it has a clear inhibitory effect on the growth and spread of pulmonary infectious pathogens (Dong et al., 2014) . Strikingly, LHQW capsule have shown therapeutic effects on inhibiting the COVID-19 based on its ability in significantly improving fever and cough symptoms in confirmed pneumonia patients. Recent clinical studies showed that disappearance rate of fever was 85.7% (57.1% in the control group), and the disappearance rate of cough was 46.7% (5.6% in the control group) after LHQW treatment.

The previous research of ALI were concentrated in direct killing for pathogens clearance. However, it lacked the evaluation and mechanism disclosure to the tissue damage in ALI. Based on the deficiencies, our studies showed a comprehensive understanding of LHQW. It is of great significance to expand the field and deepen the treatment thinking in treating respiratory infectious diseases. Our studies previously showed that LHQW can effectively ameliorate LPSinduced lung inflammation. In this current research, we focused on the core mechanism of pathological damages. We also evaluate the efficacy and potential molecular mechanism of LHQW in tissue protection and physiological reconstruction in the treatment of ALI. Importantly, the results of this study can provide some reference value for the treatment of ALI in humans.

LianHuaQingWen capsules (LHQW) were from Shijiazhuang Yiling Pharmaceutical Co., Ltd. (Shijiazhuang, China, batch number: B1509001). DEX was from Li Sheng Pharmaceutical Inc. (TianJin, China) . PS was obtained from Solarbio (Beijing, China), LPS (Escherichia coli 055: B5) and PMA were from Sigma (St. Louis, MO, USA). RPMI-1640 and Dulbecco's minimum essential medium (DMEM) were from Gibco (Grand Island, NY, USA). Heat-inactivated fetal calf serum was obtained from HyClone (Logan, UT, USA). Methyl thiazolyl tetrazolium (MTT) and dimethyl sulfoxide (DMSO) were from Amresco (Solon, OH, USA). Annexin V-propidium iodide (AV-PI) was from BD Biosciences (Franklin Lakes, NJ, USA). Caspase3 and Bradford protein assay kits were from Beyotime (Shanghai, China). Primary antibodies against phospho-JNK (#4671), total-JNK (#9258), phospho-p65 (#3033), phospho-IKK (#2697), total-IKK (#2682), IKB-a (#11930), and GRP78 (#3177S) were from Cell Signaling (Danvers, MA, USA); CHOP (ab11419), DR5 (ab199357), and SOCS3 (ab16030) were from Abcam (Cambridge, UK); b-actin (66009-1) and GAPDH (60004-1) were from Proteintech (Rosemont, IL, USA); total-p65 (sc33020), ICAM1 (sc-8439), and VCAM1 (sc-1504) were from Santa Cruz Biotechnology (Dallas, TX, USA); and Na,K ATPase (-369) was from Millipore (Burlington, MA, USA). Enzyme-linked immunosorbent assay (ELISA) kits for TRAIL, tumor necrosis factor (TNF)-a, interleukin (IL)-1b, and IL-6 were purchased from DAKEWEI (Shenzhen, China). All other chemical reagents meet the reagent specification standards.

The powder of LHQW capsules (0.4 g) was accurately weighed and extracted with 60% methanol-water (v/v) solution (20 ml) in an ultrasonic water bath for 30 min at room temperature. The supernatant solution was diluted with the same amount of water and then centrifuged for 10 min at 14,000 r/min. All the obtained solutions were filtered through 0.22 mm syringe filter before the UPLC analysis.

A total of 100 ICR male mice (6-8 weeks old, 18-20 g weight) were purchased from Si Bei Fu (Beijing, China). All mice were kept in an environment of 24°C ± 1°C and 65% humidity, under a 12-h light cycle for 3 days before starting the experiments. Water and food were available ad libitum. All experiments were carried out according to the guidelines for proper conduct of animal experiments published by the Science Council of Beijing, as well as the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines for animal research.

For each experiment, age-and weight-matched groups of mice were used. After the last drug treatment, mice were anesthetized with 4% chloral hydrate (0.4 g.kg -1 ) for 20 min and placed in the supine position on the surgical board(the statement of the use of chloral hydrate was described as following: It is undeniable that the application of chloral hydrate possesses potential risks and serious adverse effects during operative anesthesia, which include, but not limited to, post-operative ileus.). The route of administration was intraperitoneal injection. Then the trachea was exposed by a cervical incision. The whole courses were supported by ventilator. Control mice were instilled with saline, and others were treated with LPS (5 mg·kg -1 ). All of the above processes were performed on a ventilator. The mice were treated daily for one week prior to the LPS administration. Additionally, the operations were carefully monitored and under strict 

Effect Reference

Preventing Carcinogen Metabolic Activation, anti-oxidative Activity (Li, 2003) Phenylpropanoids Anticancer, antiviral, anti-inflammatory, wound healing, and antibacterial (Korkina et al., 2011) Anthraquinones Inhibit cellular proliferation, induce apoptosis, and prevent metastasis. (Huang et al., 2007) Triterpenoids Defend against signal transducer, and activate transcription and angiogenesis (Petronelli et al., 2009) Iridoids Anti-mutagenic, antispasmodic, anti-tumor, antiviral, immunomodulation (Yamazaki et al., 1994) experimental control. The anesthesia-only control group and sham-operative group were both set to avoid interference from chloral hydrate -induced unintended adverse effects. During and after the surgery, we also paid much attention to the living conditions of mice once the chloral hydrate was administrated and such post-operative care were maintained until the mice were recovered from anesthesia. For example, we put the mice on the heating pad, which set to keep the body temperature at 37°C. Besides, for the mice receiving operations, their cages were covered with soft cotton pads to prevent the unintended injury. LHQW and dexamethasone (DEX) were suspended in 0.5% (w/v) carboxymethylcellulose solution and orally administered via gavage once daily (300, 600, and 1,200 mg.kg -1 ) from day 0 to day 7. Penicillin-streptomycin (PS) was injected intramuscular once daily (10, 2.5 ml.kg -1 ).

All cells were maintained in culture medium supplemented with 10% fetal bovine serum (Gibco) at 37°C in a humidified incubator (5% CO 2 ) (SANYO, Osaka, Japan), with HPAepic and THP-1 cells in RPMI-1640 medium and RAW 264.7 cells in DMEM medium. MTT assay was used to detect living conditions of cells at 450 nm with a microplate reader. HPAepic were purchased in National Infrastructure of Cell line Resource. (According to the information provided by the company, HPAepic cells were not directly isolated from human tissues by us. Also, they were not the primary cells cultured by any companies. Instead, they were immortalized cell line and can be stably passaged in vitro).

The measurement was performed at room temperature of 24.0°C. The Anal temperatures of the mice were measured by using a digital, blunt-tipped stem thermometer(SH series), with Vaseline smearing on it, 2 h after surgery. According to the manufacturer`s instruction, half the length of the blunt-tipped stem was staying in the anus for 30 s and final temperatures were recorded when the temperature remains unchanged for 10 s. After the mice were euthanized, the lungs were removed and the wet weight was determined. The lung tissue was placed in an oven at 60°C for 48 h to obtain the dry weight. The ratio of the wet lung to the dry lung was calculated to assess tissue edema. (The arrive-guidelines of experimental-procedures were shown in Table 2 ).

Mice were firstly anesthetized with 4% chloral hydrate (0.4 g.kg-1) (intraperitoneal injection) for 20 min 24 h after surgery. After that, the trachea was fully exposed and can be clearly visualized. Then the lungs were lavaged three times with 1 ml saline each time. Alveolar lavage was centrifuged at 135 rcf ·min -1 for 5 min, the pellet on the bottom was resuspended by 1 ml 1640 medium, after that the cell suspension was put in 6 well plate and then incubated 30 min in 37°C in a humidified incubator (5% CO 2 ). Pulmonary macrophages were isolated by the adherent method. The numbers of macrophages counting were counted under a microscope at 40× magnification. The measurement of cell infiltration in BALF were measured by Cell-Counting Kit-8 (CCK-8) assays.

Total RNA was extracted from lungs using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), and single-strand cDNA was synthesized from total RNA using a Thermoscript RT-PCR synthesis kit (Thermo Fisher Scientific, Waltham, MA USA) according to the manufacturer's instructions. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an internal control for normalization. Gene transcription levels were detected with real-time PCR (AB7500, Applied Biosystems, Foster City, CA, USA) using the specific primers, Primer name and sequence were listed as: GAPDH (Mus musculus):

Briefly, 30 ml of the cell lysates were extracted and transferred into 96-well plates (Gronier, 655075). Subsequently, the samples were reacted with the substrates for firefly and Renilla luciferase Every anesthetized mice was placed in dorsal recumbency on a specialized mouse board with heating elements. This board was placed on top of a 37°C heated recirculating water pad. rectal body temperature was monitored continuously. Tissues collected posteuthanasia and timing of collection Lung tissues were collected. Timing of collection was when the animal lost its righting reflex, stopped moving, or appeared to be unconscious.

according to the manufacturer's instruction (Promega, Madison, WI, USA). Then, a Veritas Microplate Luminometer (Turner Biosystems, Sunnyvale, CA, USA) was used to sequentially detect the activities of firefly (Photinus pyralis) and Renilla (Renilla reniformis) luciferases. The final results were calculated as the fluorescence intensity of firefly luciferase corrected by the Renilla luciferase fluorescence intensity.

Lung tissues were homogenized and lysed using lysis buffer containing protease inhibitor phenylmethylsulfonyl fluoride (PMSF). Protein concentrations were measured using a bicinchoninic acid assay kit. Total sample was separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then blotted to polyvinylidene fluoride (PVDF) membranes (Merck Millipore, IPVH00010). Membranes were blocked for 2 h at room temperature with 5% bovine serum albumin (BSA). Next, incubate with primary antibodies overnight at 4°C. Horseradish peroxidase-conjugated antibodies against mouse and rabbit were used as secondary antibodies. After extensive washing, blots were developed with an enhanced chemiluminescent plus assay kit (Thermo Scientific), developed on X-ray film, and analyzed by ImageJ software (National Institutes of Health, Bethesda, MD, USA).

The levels of soluble TRAIL, monocyte chemoattractant protein 1 (MCP1), TNF-a, IL-1b, and IL-6 in the broncho alveolar lavage fluid (BALF) were determined using ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. ELISA data were obtained in duplicate from at least three independent experiments.

The supernatant of THP1 cells treated with PMA and LHQW for 24 h in 6-well plates was transferred to HPA cells (3 × 10 5 /ml). After 24 h, the HPA cells were dissociated by trypsin for apoptosis detection. Caspase3 and AV-PI assays were performed according to the manufacturer's instructions. Protein concentrations in Caspase3 assay were measured using a bradford protein assay kit according to the manufacturer's specification.

Lungs were clipped at the trachea, perfused with 4% paraformaldehyde (PFA), removed, and fixed for 24 h in 4% PFA. Lungs were embedded in paraffin (ASP200S, Leica, Wetzlar, Germany) and cut into 5-mm thick sections. Sections were stained with TUNEL (Takara Biomedicals, Tokyo, Japan) or NKAa1 (clone C464.6, EMD Millipore, Burlington, MA, USA) after antigen retrieval with 10 mM sodium citrate at 95°C for 20 min according to the manufacturer's instructions. Analyses were performed with ImageJ software.

Data were analyzed using SPSS 20.0 (IBM, Armonk, NY, USA). Values were presented as mean ± standard deviation.

Comparisons among groups were performed using Student's t tests or one-way analysis of variance. In all cases, P < 0.05 was considered statistically significant.

UPLC was performed to identify the chemical compounds of each herb contained in LHQW. The 12 main active ingredient chemical compositions were as follows: Salidroside (1701.25 mg.g -1 ), Chlorogenic acid (2,492.15 mg.g -1 ), Forsythoside E (1620.78 mg.g -1 ), Cryptochlorogenic acid (1,851.64 mg.g -1 ), Amygdalin (1,455.39 mg.g -1 ), Sweroside (813.18 mg.g -1 ), Hyperin (151.73 mg.g -1 ), Rutin (121.17 mg.g -1 ), Forsythoside A (2,536.34 mg.g -1 ), Phillyrin (1521.45 mg.g -1 ), Rhein (1102.06 mg.g -1 ), Glycyrrhizic acid (1,680.43 mg.g -1 ) (Jia et al., 2015) .

To evaluate the pharmacodynamics of LHQW, we first measured anal temperature. Compared to the NC group, the anal temperature in the ALI model group decreased to 25.3°C, which was significantly increased after LHQW and PS 10 ml.kg-1 treatment. Notably, there was a synergistic effect of LHQW 1,200 mg.kg-1 combined with PS 2.5 ml.kg-1 compared with PS 2.5 ml.kg-1 alone ( Figure 1A) . Because of the importance of edema for ALI progression and prognosis, we assessed the wet and dry weights for lungs and the ratio. After LPS injection, the ratio was increased nearly 3-fold, but this was significantly attenuated with LHQW and PS 10 ml.kg -1 treatment. We also observed a significant increasing in the ratio after LHQW 1,200 mg.kg -1 combined with PS 2.5 ml.kg-1 compared with PS 2.5 ml.kg-1 alone ( Figure 1B) . Furthermore, LHQW combined with PS (2.5 or 10 ml.kg-1) treatment were having similar effects. To assess the chemotactic ability of infiltrated cells, MCP1 concentration in BALF was measured by ELISA after LPS treatment. The concentration of MCP1 decreased significantly in mice treated with LHQW. Subsequently, LHQW 1200 mg.kg-1 also had a synergistic effect of PS 2.5 ml.kg-1 compared with PS 2.5 ml.kg-1 alone ( Figure 1C) .

The total infiltrated cells in BALF, which is an indicator of the lung inflammatory response. The numbers were obviously increased by LPS; however, this increase was significantly reduced by LHQW and PS 10 ml.kg-1 treatment. Consistent with our hypothesis, total infiltrated cell numbers were also decreased by at least 2-fold after LHQW 1200 mg.kg-1 combined with PS 2.5 ml.kg-1 compared with PS 2.5 ml.kg-1 alone ( Figures 1D-F) . Alveolar epithelial Na,K ATPases drive the clearance of excess edema fluid, and passive activity of Na,K ATPase in the lung leads to edema due to an imbalance of fluid and salt (Peteranderl et al., 2016) . Notably, Na,K ATPase activity was significantly decreased by LPS, but this was reversed by LHQW and PS 10 ml.kg-1. Moreover, LHQW 600, 1,200 mg.kg-1 worked synergistically with PS 2.5 ml.kg-1 to enhance Na,K ATPase activity ( Figures 1G, H) . Collectively, these results demonstrate that LHQW significantly protected lung tissue from inflammatory damages and decreased the required antibiotics dose in an LPS-induced ALI mouse model. LHQW may have a role in decreasing antibiotic abuse and resistance.

We next measured activity of the transcription factor nuclear factor (NF-kB) (Hamid et al., 2011; Oeckinghaus et al., 2011) . We first evaluated the impact of LHQW on NF-kB with dual luciferase reporter gene assays in RAW 264.7 cells. The results clearly showed that LPS-induced macrophages had increased fluorescence intensity in cells transfected with the NF-kBdependent luciferase reporter construct, subsequently, which was significantly reversed by LHQW ( Figure 2A) . Additionally, the expression of phospho-P65, phospho-IKK, and IKB-a in THP1 cells were detected by western blot. Expression of phospho-P65 and phospho-IKK were significantly upregulated, while IKB-a was obviously downregulated after LPS treatment. These changes were clearly reversed with LHQW treatment (Figures 2B, C) . Furthermore, we prepared VCAM1 and ICAM1 antibodies (Yang et al., 2015) for western blot analysis in THP1 cells and detected obviously increased expression of both proteins in response to LPS. Both increases were significantly downregulated after LHQW 1,200 mg.kg-1 treatment and VCAM1 was more markedly downregulated than ICAM1 ( Figures 2D, E) . ELISA assays were performed to assess the concentrations of TNF-a, IL-1b, and IL-6 in BALF. All three pro-inflammatory cytokines were obviously increased in response to LPS ( Figure  2F ). However, we detected marked decreases in TNF-a, IL-1b, and IL-6 concentrations after LHQW 1200 mg.kg-1 and PS 10 ml.kg-1 treatment. TNF-a and IL-1b concentrations were also decreased by LHQW (600 or 1,200 mg.kg-1) combined with PS 2.5 ml.kg-1, and IL-6 concentration was decreased observably by LHQW (1200 mg.kg-1) combined with PS 2.5 ml.kg-1 compared with PS 2.5 ml.kg-1 alone. The expression levels of Phospho-P65, VCAM1, and ICAM1 were consistent with in vitro evidence in alveolar macrophages ( Figures 2G, H) . Taken together, these results show that LHQW inhibited the expression and secretion of inflammatory molecules and dampened inflammatory responses by targeting macrophages in vitro studies.

To detect the ERS markers CHOP and GRP78, we first prepared CHOP primers (Table 1) for reverse-transcription PCR. CHOP expression in LPS-induced THP1 cells was clearly upregulated; however, there was a 5-fold change with LHQW 500 mg/kg treatment. We also measured CHOP and GRP78 in western blot analyses, which obviously upregulated CHOP and GRP78 expression in response to LPS. Both ERS markers were dramatically downregulated by at least 1-fold change after LHQW treatment. Consistent results were obtained in the alveolar macrophages (Figures 3A1, D-G) . These results demonstrate that LHQW is a candidate for alleviating LPSinduced ERS.

Next, we performed additional reverse-transcription PCR assays and found that and test TRAIL transcription was decreased by LHQW (300, 600 mg.kg-1) treatment compared with LPS-induced THP1 cells ( Figure 3A2 ). To measure TRAIL secretion, we performed ELISA assays by using supernatant of THP1 cells and BALF from mice. Both in vitro and in vivo, TRAIL secretion was clearly upregulated after LPS induction compared with the NC group, but this was dramatically downregulated by LHQW treatment. We hypothesized that TRAIL secretion might be closely related with ERS in macrophages. The ERS inhibitor PBA was used to test this in THP1 cells. There was no significant difference in the response to PBA between the LHQW and LPS groups ( Figures 3B, C) . To identify the specificity of LHQW for an effect on TRAIL, we detected Death Receptor 5 (DR5), the ligand of TRAIL (Liu, et al.) We prepared DR5 antibody for western blot assay in HPA cells that had been treated with supernatant from THP1 cells. DR5 expression was essentially unchanged in response to LPS and LHQW treatment ( Figures 3H, I) . Overall, these results show that LHQW alleviated LPS-induced ERS and TRAIL expression in macrophages in vitro and in vivo.

Crosstalk between macrophages and epithelial cells eventually leads to disease progression and complications (Peteranderl et al., 2016) . Firstly, MTT assays showed that LHQW increased the cell counting of HPA cells in the macrophage-epithelial cocultural model ( Figure 4A ). AV-PI reagents were added to cells prior to flow cytometry. There were no significant differences in numbers of necrotic epithelial cells (AV − PI + ). TM, which promotes ERS, significantly increased the mean number of HPA cells in early apoptosis (AV + PI − ), which was significantly reduced by LHQW treatment ( Figure 4B ). Next, Capase3 kits were used to determine the mechanism by which LHQW inhibited apoptosis. Mechanistically, caspase3 activity levels were highly consistent with the AV-PI results ( Figure 4C ). To further confirm the antiapoptotic ability of LHQW, TUNEL staining was performed. We observed increased numbers of apoptotic cells in response to LPS 5 mg.kg-1 compared with the NC and VACANT (with no surgery) groups. As expectedly, dramatic reductions in apoptosis were observed after LHQW, PS10 ml.kg-1, and DEX 5 mg.kg-1 treatment ( Figure 4D ). LHQW effectively protected alveolar epithelial cells against TRAIL-induced apoptosis in a macrophage-epithelial co-cultural model. 

To determine the ability of LHQW to reverse ERS-mediated TRAIL up-regulation, we prepared a SOCS3 antibody for western blot assays in three macrophage lines: THP1 cells, RAW 264.7 cells, and alveolar macrophages. We detected increased expression in response to LHQW treatment in THP1 cells and RAW 264.7 cells (Figures 5A, B) . Furthermore, consistent with vitro results, SOCS3 expression was upregulated nearly 1-fold in alveolar macrophages from mice treated with LHQW 1,200 mg.kg-1 ( Figure 5C ). We finally turned our attention to the JNK pathway, which is closely associated with TRAIL transcription and translation. Western blots clearly showed that JNK expression was markedly increased in the LPS group compared to the NC group, but levels were significantly downregulated after LHQW and SP600125 treatment compared with the LPS group ( Figure  5D ). Together, these findings indicate that LHQW attenuated the increase in SOCS3 expression, with the ultimate result of restricting TRAIL production.

Here, we investigated how LHQW affects epithelial cells apoptosis and ERS. By targeting its regulatory effects in the JNK pathway, we revealed that LHQW could decrease SOCS3 expression and as a resultant, restrict TRAIL production in macrophages. Our results provide evidence that LHQW is an effective treatment for ALI and suggests that it could be used as an adjunctive treatment to antibiotics.

Accumulating evidence indicates that ALI is not only the core pathological process of bacterial infection, but also the common pathological process of damage of various respiratory infectious diseases induced by viruses, mycoplasma, fungi and other pathogenic agents. The etiology of respiratory infectious diseases system is caused by the invasion of pathogens or foreign bodies, however, the pathogenic mechanism and damage causes of diseases are more due to the body's inflammatory imbalance and immune damage (Tabas, 2010; Alessandri et al., 2013; Condamine et al., 2014; Huang et al., 2015) . Thus, treatment of respiratory infections diseases have provided insight into pathogen-host interactions, and hostdirected therapeutic strategies are becoming feasible adjuncts to standard antimicrobial treatment (Zumla et al., 2016) .

Under the background of global outbreak of COVID-19, mortality from the most severe respiratory infections disease remains high. Subsequently, lots of drugs that have once shown promising antiviral efficacy have nearly failed in clinical trials. However, traditional Chinese medicine LHQW capsule can significantly improve the symptoms of COVID-19 suspected cases such as fever, cough, fatigue, shortness of breath, and reduce the proportion of severe cases, providing preliminary clinical evidence for the prevention and treatment of the disease. The facts remind us again that focusing on immunity is of great clinical significance to develop new strategies for the treatment of respiratory infectious diseases, which is a good way to make up for the defects of pathogen inhibition, improve the efficiency of pathogen inhibition and reduce tissue damage. According to the theory of traditional Chinese medicine, we focus on "people" of the disease, highlight the "sick people" and "human diseases" integrated interactions. Newer approaches to improving treatment outcomes would put its insights into pathogen-host interactions, the host's innate and acquired immune responses, which are leading to identification and development of a wide range of host-directed therapies with different mechanisms of action. Host-directed therapies targeting host immune and inflammatory pathways to enhance immune responses and alleviate immunopathology could benefit treatment outcomes in a range of bacterial, viral, and parasitic diseases (Cheng et al., 2014) (Zumla et al., 2016) .

Recent studies showed that the lung's response to inflammatory conditions was characterized by epithelial injury, pulmonary inflammation, formation of distinctive fibroblasts and excessive extracellular matrix accumulation (Galkina and Ley, 2009 ). In our study, the tracheal injection of LPS for 24 h can slightly lead to alveolar spaces shrinks and alveolar wall thickening compared to normal group. However, we can hardly observe these symptoms treated with LHQW 1,200 mg.kg-1. We could conclude that LHQW might have potential in resolving pulmonary fibrosis. In addition, some researchers said that pulmonary fibrosis has an indispensable relationship with inflammatory damage and tissue structure destruction (Seimon et al., 2010) .

It is well-known that tissue damage is a common feature of many infectious diseases, specifically in ALI (Headland and Norling, 2015) . (Freire and Van Dyke, 2013) . The interactions between macrophages and epithelial cells, which eventually leads to disease progression, were recently revealed as the therapeutic target in ALI. Subsequently, they can reverse the pathological process of ALI and protect organs from damaging (Hogner et al., 2013; Peteranderl et al., 2016) . Under the inflammatory conditions, TRAIL facilitated the inflammatory reaction that promotes unspecific tissue injury and disease severity. TRAIL is closely related to the ERS response and might activate DRs on target cell membranes or alter intracellular pathways, and the pathogen itself might exploit TRAIL-induced pathways for its own survival and replication (Tiwary et al., 2010; Liu et al., 2016) . Therefore, TRAIL or its downstream signaling events might reflect ALI severity. Importantly, the regulation of TRAIL expression in the setting of ERS was accompanied by a significant decrease in SOCS3 (Kim et al., 2013; Chen et al., 2015) (Huang et al., 2015) . In summary, our studies suggested that LHQW can enhance SOCS3 expression to reverse ERSinduced aberrant expression of TRAIL through JNK pathway, which is closely related with ERS-induced transcription and translation of TRAIL. Based on the analysis above, we concluded that LHQW have potential in alleviating tissue damage induced by TRAIL and it just provide new insight to infectious disease.

In conclusion, the present study demonstrated that LHQW effectively ameliorated inflammatory damage, blocking ALI progression. Furthermore, we need a systematic analysis to determine how LHQW regulate the immune injury and pharmacologically protect tissues from damaging.

The datasets generated for this study are available on request to the corresponding author.

The animal study was reviewed and approved by Laboratory Animal Ethics Committee of the Institute of basic theory of traditional Chinese medicine, of the China Academy of Chinese Medical Sciences (license number SCXK 2016-0021).

QR and QL participated in the manuscript writing and experimental design and performed the experiments. LS, JY, TL, LL, and ZZ participated in the experiments. QY, YL, YC, XW, YW, and WC participated in the manuscript writing, manuscript editing, and data analysis. XZ participated in the manuscript writing, experimental design, and data analysis. All authors contributed to the article and approved the submitted version. 

Resolution of inflammation: mechanisms and opportunity for drug development

Endoplasmic Reticulum Stress Cooperates in Zearalenone-Induced Cell Death of RAW 264.7 Macrophages

Antibiotic alternatives: the substitution of antibiotics in animal husbandry?

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis

Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Evidence-Based Complement

Natural resolution of inflammation

Immune and inflammatory mechanisms of atherosclerosis (*)

Incidence and Outcomes of Acute Lung Injury

Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure

The resolution of inflammation: Principles and challenges

Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia

Anticancer properties of anthraquinones from rhubarb

Molecular mechanism of ER stress-induced gene expression of tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) in macrophages

Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury

Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS

Inhibition of endoplasmic reticulum stress alleviates lipopolysaccharideinduced lung inflammation through modulation of NF-kappaB/HIF-1alpha signaling pathway

Plant phenylpropanoids as emerging anti-inflammatory agents

Therapeutic options for the 2019 novel coronaviru-nCoV)

Flavonoids: Promising Anticancer Agents

Stagedependent effects of exogenous TRAIL on atherogenesis: role of ER stressmediated sensitization of macrophage apoptosis

Crosstalk in NF-kappaB signaling pathways

Blocking of CD27-CD70 Pathway by Anti-CD70 Antibody Ameliorates Joint Disease in Murine Collagen-Induced Arthritis

Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection

Triterpenoids as new promising anticancer drugs

Acute lung injury outside of the ICU: incidence in respiratory isolation on a general ward

Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress

Macrophage death and defective inflammation resolution in atherosclerosis

Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis

Sex-associated expression of co-stimulatory molecules CD80, CD86, and accessory molecules, PDL-1, PDL-2 and MHC-II, in F480+ macrophages during murine cysticercosis

ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis

Promotion of neuronal differentiation of pc12h cells by natural lignans and iridoids

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2020.522729/ full#supplementary-material